SCHEMBL15739458

SCHEMBL15739458

O=C(O)/C=C/CNC1CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.47
HTR2A P28223 3/20 0.43
HTR2C P28335 3/20 0.43
HTR2B P41595 3/20 0.43
SIGMAR1 Q99720 3/20 0.43
TSHR P16473 3/20 0.39
LMNA P02545 3/20 0.39
GABRR1 P24046 2/20 0.39
GABRR2 P28476 2/20 0.39
BLM P54132 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
GABRR3 A8MPY1 1/20 0.39
APEX1 P27695 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
HTT P42858 2/20 0.38
NPC1 O15118 1/20 0.38
GAA P10253 1/20 0.38
TP53 P04637 2/20 0.33
EGLN1 Q9GZT9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29185139 1.00 POLB (0.47) POLBHTR2AHTR2CHTR2BSIGMAR1
SCHEMBL8916490 0.90 SMN1; SMN2 (0.52) POLBHTR2AHTR2CHTR2BSIGMAR1
SCHEMBL2697384 0.90 SMN1; SMN2 (0.52) POLBHTR2AHTR2CHTR2BSIGMAR1
SCHEMBL2697385 0.90 SMN1; SMN2 (0.52) POLBHTR2AHTR2CHTR2BSIGMAR1
SCHEMBL30039829 0.86 HTR2A (0.37) POLBHTR2AHTR2CHTR2BSIGMAR1
SCHEMBL20893422 0.83 HTR2A (0.38) POLBHTR2AHTR2CHTR2BSIGMAR1
SCHEMBL30153867 0.82 POLB (0.41) POLBHTR2AHTR2CHTR2BSIGMAR1
SCHEMBL18909623 0.81 HTR2A (0.34) POLBHTR2AHTR2CHTR2BSIGMAR1
SCHEMBL31269358 0.80 HTR2A (0.35) POLBHTR2AHTR2CHTR2BSIGMAR1
SCHEMBL30154000 0.80 HTR2A (0.35) POLBHTR2AHTR2CHTR2BSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115304602-A Pyrazinopyrazinonaphthyridinedione derivatives, preparation method and medical application thereof 浙江海正药业股份有限公司 2022-11-08 CN disclosed
WO-2016004272-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE PHARMACYCLICS LLC (US) 2016-01-07 WO disclosed
WO-2016004305-A2 INHIBITORS OF BRUTON'S TYROSINE KINASE PHARMACYCLICS LLC (US) 2016-01-07 WO disclosed
WO-2014078578-A1 PYRROLOPYRIMIDINE COMPOUNDS AS KINASE INHIBITORS PHARMACYCLICS, INC. (US) 2014-05-22 WO disclosed